Aurinia Pharmaceuticals Inc

AED55.82
AED
Last updated on --.
24h volume893.27K
24h highest56.4127 AED
24h lowest55.3476 AED
24h Price movement-0.13%

AUPH recent prices

24 Hours
-0.13%-AED0.073454
30 days
-7.03%-AED4.224
60 days
+6.66%+AED3.489
90 days
+5.47%+AED2.901

Key data

Previous close55.8985 AED
Market cap7.51B AED
Volume893.27K
P/E ratio6.860000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)8.5207 AED
Net income (FY)1.10B AED
Revenue (FY)1.10B AED
Last report date7 May 2026

About Aurinia Pharmaceuticals Inc

PHARMACEUTICAL PREPARATIONS
HeadquartersEDMONTON
Employees (FY)128.00
Revenue per employee (FY)8.56M AED
Net income per employee (FY)8.56M AED
Listed onNasdaq
Official website

AUPH conversion tables

AUPHAUPH
AEDAED
0.5 AUPH27.91 AED
1 AUPH55.82 AED
5 AUPH279.12 AED
10 AUPH558.25 AED
AEDAED
AUPHAUPH
0.5 AED0.0089566 AUPH
1 AED0.017913 AUPH
5 AED0.089566 AUPH
10 AED0.17913 AUPH

FAQ

AUPH is trading at AED55.82, -0.13% over the last 24 hours. Track live moves on the price chart at the top of this page.
The AUPH stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. AUPH is currently trading at AED55.82, -0.13% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on AUPH price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. AUPH's P/E ratio is currently 6.860000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from AUPH; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against AUPH's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Aurinia Pharmaceuticals Inc's market cap is currently 7.51B AED. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume893.27K
24h highest56.4127 AED
24h lowest55.3476 AED
24h Price movement-0.13%
AUPHAUPH
AEDAED
Start trade with AUPH Perpetual